Viewing
|Articles|March 1, 2007

FDA grants orphan status to two Lux products

The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME